Nancy Li Selected Research

20,21-epoxyresibufogenin-3-formate

1/2018

Disease modifying actions of interleukin-6 blockade in a rat model of bone cancer pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nancy Li Research Topics

Disease

2	Neoplasms (Cancer) 01/2018 - 06/2017
1	Neuroblastoma 01/2020
1	Bone Neoplasms (Bone Cancer) 01/2018
1	Bone Resorption 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Hypersensitivity (Allergy) 01/2018
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Pain (Aches) 01/2018
1	Tauopathies 01/2018
1	Bone Fractures (Bone Fracture) 01/2018
1	Skin Neoplasms (Skin Cancer) 10/2013
1	Asthma (Bronchial Asthma) 04/2011
1	Necrosis 03/2011

Drug/Important Bio-Agent (IBA)

2	EnzymesIBA 01/2018 - 10/2013
1	Amyloid (Amyloid Fibrils)IBA 01/2018
1	hexosaminidase CIBA 01/2018
1	20,21-epoxyresibufogenin-3-formateIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	Biological ProductsIBA 10/2013
1	LipidsIBA 04/2011
1	MicroRNAs (MicroRNA)IBA 03/2011

Therapy/Procedure

1	Therapeutics 01/2020
1	Drug Therapy (Chemotherapy) 06/2017
1	Radiotherapy 06/2017